Literature DB >> 29953194

Waist Circumference Rather than Body Mass Index is Better Indicator of Insulin Resistance in Type 2 Diabetes Mellitus in North Indian Population.

Kiran Prakash, Dinu S Chandran, Rajesh Khadgawat, Ashok Kumar Jaryal, Kishore Kumar Deepak.   

Abstract

Obesity and insulin resistance (IR) are associated with type 2 diabetes mellitus (DM). Obesity can be quantified by body mass index (BMI) and waist circumference (WC). Similarly, IR is commonly quantified by fasting-plasma-insulin (FPI) and Homeostatic model assessment (HOMA-IR). We aimed our study to find correlation between obesity-parameters and IR especially in the Indian population where despite lower BMI there is more prevalence of type 2 DM. In 34 uncomplicated patients of type 2 DM weight and WC were measured and BMI was calculated. HOMA-IR and FPI level were estimated to assess IR. Significant correlation was found between HOMA-IR and WC (r = +0.368, P = 0.0324) but it was non-significant between HOMAIR and BMI. Correlations were also not significant between FPI and WC or BMI. In conclusion, HOMA-IR and WC are better measures of IR and obesity as compared to FPI and BMI, respectively in type 2 DM.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 29953194

Source DB:  PubMed          Journal:  Indian J Physiol Pharmacol        ISSN: 0019-5499


  2 in total

1.  Development and multi-cohort validation of a clinical score for predicting type 2 diabetes mellitus.

Authors:  Vanessa Kraege; Peter Vollenweider; Gérard Waeber; Stephen J Sharp; Maite Vallejo; Oscar Infante; Mohammad Reza Mirjalili; Fatemeh Ezoddini-Ardakani; Hassan Mozaffari-Khosravi; Mohammad Hasan Lotfi; Masoud Mirzaei; Marie Méan; Pedro Marques-Vidal
Journal:  PLoS One       Date:  2019-10-09       Impact factor: 3.240

2.  Comparison of the Ability of Anthropometric Indices to Predict the Risk of Diabetes Mellitus in South African Males: SANHANES-1.

Authors:  Machoene D Sekgala; Ronel Sewpaul; Maretha Opperman; Zandile J Mchiza
Journal:  Int J Environ Res Public Health       Date:  2022-03-09       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.